Wilmington-based Incyte receives FDA approval for therapy to treat a rare cancer By: Philadelphia Business Journal via Business Journals April 20, 2020 at 10:31 AM EDT The drug was approved to treat cholangiocarcinoma, a rare type of cancer that occurs in the bile duct outside the liver. Read More >>
